The Ontario government has taken a step forward in cancer treatment with the launch of the new Funding Accelerated for Specific Treatments (FAST) program. A one-of-its-kind fast-track initiative, this program aims to provide easy and swift access to drugs and advanced treatments for cancer patients in Ontario. It means patients will no longer need to […]

A latest study conducted by the Journal of Clinical Oncology states that one in three relapsed or treatment-resistant B-cell acute lymphoblastic leukemia (R/R B-ALL) patients remained in long-term remission post-CAR T-cell therapy obecabtagene autoleucel (obe-cel) – a novel advancement in cancer immunotherapy. In the latest FELIX trial updates, medical researchers observed that 40% patients were […]